These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 33293807)
21. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001 [TBL] [Abstract][Full Text] [Related]
22. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells. Alkhatib MH; Bawadud RS; Gashlan HM Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596 [TBL] [Abstract][Full Text] [Related]
23. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, Shaarani S; Hamid SS; Mohd Kaus NH Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648 [TBL] [Abstract][Full Text] [Related]
24. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity. Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570 [TBL] [Abstract][Full Text] [Related]
26. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer. Moubarak MM; Chanouha N; Abou Ibrahim N; Khalife H; Gali-Muhtasib H World J Clin Oncol; 2021 May; 12(5):342-354. PubMed ID: 34131566 [TBL] [Abstract][Full Text] [Related]
27. Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration. Abdelwahab SI; Sheikh BY; Taha MM; How CW; Abdullah R; Yagoub U; El-Sunousi R; Eid EE Int J Nanomedicine; 2013; 8():2163-72. PubMed ID: 23818776 [TBL] [Abstract][Full Text] [Related]
28. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
29. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496 [TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanisms of Thymoquinone as Anticancer Agent. Alhmied F; Alammar A; Alsultan B; Alshehri M; Pottoo FH Comb Chem High Throughput Screen; 2021; 24(10):1644-1653. PubMed ID: 33115388 [TBL] [Abstract][Full Text] [Related]
32. In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes. Fahmy HM Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1465-1476. PubMed ID: 31377882 [TBL] [Abstract][Full Text] [Related]
33. Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines. Shariare MH; Khan MA; Al-Masum A; Khan JH; Uddin J; Kazi M Molecules; 2022 Oct; 27(19):. PubMed ID: 36235288 [TBL] [Abstract][Full Text] [Related]
34. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer. Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Enhanced Cytotoxicity Effect of Repurposed Drug Simvastatin/Thymoquinone Combination against Breast Cancer Cell Line. Kumari P; Dang S Cardiovasc Hematol Agents Med Chem; 2024; 22(3):348-366. PubMed ID: 37907488 [TBL] [Abstract][Full Text] [Related]
36. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Velho-Pereira R; Kumar A; Pandey BN; Jagtap AG; Mishra KP Cell Biol Int; 2011 Oct; 35(10):1025-9. PubMed ID: 21557727 [TBL] [Abstract][Full Text] [Related]
38. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231. Sjs B; K K; A P; P H; B SR; S S Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706 [TBL] [Abstract][Full Text] [Related]
39. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA Nutrients; 2022 May; 14(10):. PubMed ID: 35631261 [TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. Abu-Dahab R; Odeh F; Ismail SI; Azzam H; Al Bawab A Pharmazie; 2013 Dec; 68(12):939-44. PubMed ID: 24400439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]